These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Metastatic renal cell carcinoma: many treatment options, one patient. Rini BI J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934 [TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764 [TBL] [Abstract][Full Text] [Related]
6. Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review. Murali R; Gopalakrishnan AV Med Oncol; 2023 Nov; 40(12):355. PubMed ID: 37955787 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy. Al-Ali BM; Ress AL; Gerger A; Pichler M Anticancer Res; 2012 Sep; 32(9):3727-32. PubMed ID: 22993312 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics. Takahashi M; Sugimura J; Yang X; Vogelzang N; Teh BS; Furge K; Teh BT Adv Cancer Res; 2003; 89():157-81. PubMed ID: 14587873 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of renal cell carcinoma. Erlandsson R Cancer Genet Cytogenet; 1998 Jul; 104(1):1-18. PubMed ID: 9648552 [TBL] [Abstract][Full Text] [Related]
11. Novel therapies for renal cell carcinoma. Fishman M; Seigne J; Antonia S Expert Opin Investig Drugs; 2001 Jun; 10(6):1033-44. PubMed ID: 11772233 [TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of renal cell carcinoma. Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024 [TBL] [Abstract][Full Text] [Related]
13. Molecular biology of renal cell cancer and the identification of therapeutic targets. Iliopoulos O J Clin Oncol; 2006 Dec; 24(35):5593-600. PubMed ID: 17158545 [TBL] [Abstract][Full Text] [Related]
14. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma. Arsanious A; Bjarnason GA; Yousef GM Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329 [TBL] [Abstract][Full Text] [Related]
15. Update on the biology and management of renal cell carcinoma. Dutcher JP J Investig Med; 2019 Jan; 67(1):1-10. PubMed ID: 30455223 [TBL] [Abstract][Full Text] [Related]
16. What can molecular pathology contribute to the management of renal cell carcinoma? Stewart GD; O'Mahony FC; Powles T; Riddick AC; Harrison DJ; Faratian D Nat Rev Urol; 2011 May; 8(5):255-65. PubMed ID: 21487387 [TBL] [Abstract][Full Text] [Related]
17. Novel approaches in the therapy of metastatic renal cell carcinoma. Lam JS; Leppert JT; Belldegrun AS; Figlin RA World J Urol; 2005 Jul; 23(3):202-12. PubMed ID: 15812574 [TBL] [Abstract][Full Text] [Related]
18. Immunobiology and Metabolic Pathways of Renal Cell Carcinoma. Braun DA; Chakraborty AA Hematol Oncol Clin North Am; 2023 Oct; 37(5):827-840. PubMed ID: 37246090 [TBL] [Abstract][Full Text] [Related]
19. Update on targeted therapies for clear cell renal cell carcinoma. Singer EA; Gupta GN; Srinivasan R Curr Opin Oncol; 2011 May; 23(3):283-9. PubMed ID: 21330923 [TBL] [Abstract][Full Text] [Related]